Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment: A Narrative Review of Literature for Clinical Practice.
J Clin Rheumatol
; 27(6): 248-259, 2021 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-31693649
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lupus Erythematosus, Cutaneous
/
Lupus Erythematosus, Systemic
Type of study:
Diagnostic_studies
/
Observational_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
J Clin Rheumatol
Journal subject:
FISIOLOGIA
/
ORTOPEDIA
/
REUMATOLOGIA
Year:
2021
Document type:
Article
Country of publication:
United States